Preclinical and translational tools and strategies

CELL AND GENE THERAPY INSIGHTS

Preclinical and translational tools and strategies

February 2022
Preclinical and translational tools and strategies
Download PDF

Expert Insight

Considerations in establishing meaningful clinical endpoints in Duchenne muscular dystrophy & other neuromuscular disorders

Considerations in establishing meaningful clinical endpoints in Duchenne muscular dystrophy & other neuromuscular disorders

Carl A. Morris, Roxana Donisa Dreghici, J. Patrick Gonzalez
17 February 2022
Read

Interview

Keys to the successful preclinical-clinical translation of next-gen CAR-T cell therapy

Keys to the successful preclinical-clinical translation of next-gen CAR-T cell therapy

Devon J Shedlock
8 February 2022
Read
Advancing the application of organoids, tissue-on-a-chip, and other emerging <em> in vitro </em>models to support cell and gene therapy

Advancing the application of organoids, tissue-on-a-chip, and other emerging in vitro models to support cell and gene therapy

Jason Ekert, Marie Davies, Pelin Candarlioglu
2 February 2022
Read